EGF and breast carcinoma: In this study, we identified ADD1 as a novel substrate of Cdk5 (Fig. 1) and demonstrated that ADD1 phosphorylation at T724 by Cdk5 is important for EGF-induced cell migration and invasion in MDA-MB-231 breast cancer cells (Fig. 6).